Abstract
To investigate the expression patterns of autophagy marker light chain protein 3 (LC3A) in keratoacanthoma (KA). KAs are generally regarded as benign but malignant behavior, including rare metastases, may occur. 85 KAs were assessed for the LC3A autophagic protein by immunohistochemistry. Diffuse cytoplasmic staining and a “stone-like structure” (SLS) characterized positive expression. Thirty-four out of 85 KAs (40%) had diffuse cytoplasmic LC3A immunostaining (percentage of positive cells ranging from 5 to 60%). In contrast, only 4 of the 85 KAs (4.7%) expressed SLSs. Only one SLS was detected per histologic section of each tumor. The p53 oncoprotein was encountered in all cases with expression ranging from 1 to 90% of cells (median 30%). The Ki-67 index was expressed in 63 cases (74% of cases; range 1–50% of cells; median value 5%). Neither of these two parameters nor diffuse cytoplasmic LC3A staining was significantly correlated with SLS expression or lack thereof. Expression of SLSs, a hallmark of malignancy, was found in 4.7% of KAs. Further study is necessary to determine whether this fraction represents the exceptional cases that harbor latent malignant potential.
Similar content being viewed by others
References
Savage JA, Maize JC, Sr. Keratoacanthoma clinical behavior: a systematic review. Am J Dermatopathol. 2014;36:422–9.
Oellers P, Karp CL, Shah RR, et al. Conjunctival keratoacanthoma. Br J Ophthalmol. 2014;98:275–6.
Ko CJ. Keratoacanthoma: facts and controversies. Clin Dermatol. 2010;28:254–61.
Piscioli F, Boi S, Zumiani G, et al. A gigantic, metastasizing keratoacanthoma. Report of a case and discussion on classification. Am J Dermatopathol. 1984;6:123–9.
Hodak E, Jones RE, Ackerman AB. Solitary keratoacanthoma is a squamous-cell carcinoma: three examples with metastases. Am J Dermatopathol. 1993;15:332–42.
Mandrell JC, Santa Cruz D. Keratoacanthoma: hyperplasia, benign neoplasm, or a type of squamous cell carcinoma? Semin Diagn Pathol. 2009;26:150–63.
Weedon D. Weedon’s skin pathology. Keratoacanthoma centrifugum marginatum. Edinburg: Churchill Livingstone Elsevier; 2010. p. 702–8.
Godbolt AM, Sullivan JJ, Weedon D. Keratoacanthoma with perineural invasion: a report of 40 cases. Australas J Dermatol. 2001;42:168–71.
Weedon D, Malo J, Brooks D, et al. Keratoacanthoma: is it really a variant of squamous cell carcinoma? ANZ J Surg. 2010;80:129–30.
Ra SH, Su A, Li X, et al. Keratoacanthoma and squamous cell carcinoma are distinct from a molecular perspective. Mod Pathol. 2015;28:799–806.
Gleich T, Chiticariu E, Huber M, et al. Keratoacanthoma: a distinct entity? Exp Dermatol. 2016;25:85–91.
Ogita A, Ansai SI, Misago N, et al. Histopathological diagnosis of epithelial crateriform tumors: Keratoacanthoma and other epithelial crateriform tumors. J Dermatol. 2016;43:1321–31.
Manstein CH, Frauenhoffer CJ, Besden JE. Keratoacanthoma: is it a real entity? Ann Plast Surg. 1998;40:469–72.
Sarma D. Keratoacanthoma should be reported as “well differentiated squamous cell carcinoma, Keratoacanthoma Type”: a dermatopathologist’s view. Internet J Dematol. 2006;5:1.
Goldenberg G, Patel S, Patel MJ, et al. Eruptive squamous cell carcinomas, keratoacanthoma type, arising in a multicolor tattoo. J Cutan Pathol. 2008;35:62–4.
Sivridis E, Koukourakis MI, Zois CE, Ledaki I, Ferguson DJ, Harris AL, Gatter KC, Giatromanolaki A. LC3A-positive light microscopy detected patterns of autophagy and prognosis in operable breast carcinomas. Am J Pathol. 2010;176:2477–89.
Giatromanolaki A, Sivridis E, Mendrinos S, et al. Autophagy proteins in prostate cancer: relation with anaerobic metabolism and Gleason score. Urol Oncol. 2014;32:39.e11-8.
Giatromanolaki A, Koukourakis MI, Harris AL, et al. Prognostic relevance of light chain 3 (LC3A) autophagy patterns in colorectal adenocarcinomas. J Clin Pathol. 2010;63:867–72.
Sivridis E, Giatromanolaki A, Karpathiou G, et al. LC3A-positive “stone-like” structures in cutaneous squamous cell carcinomas. Am J Dermatopathol. 2011;33:285–90.
Karpathiou G, Sivridis E, Koukourakis MI, et al. Light-chain 3A autophagic activity and prognostic significance in non-small cell lung carcinomas. Chest. 2011;140:127–34.
Sivridis E, Koukourakis MI, Mendrinos SE, et al. Patterns of autophagy in urothelial cell carcinomas—the significance of “stone-like” structures (SLS) in transurethral resection biopsies. Urol Oncol. 2013;31:1254–60.
Giatromanolaki A, Sivridis E, Mitrakas A, et al. Autophagy and lysosomal related protein expression patterns in human glioblastoma. Cancer Biol Ther. 2014;15:1468–78.
Sivridis E, Giatromanolaki A, Liberis V. Autophagy in endometrial carcinomas and prognostic relevance of ‘stone-like’ structures (SLS) What is destined for the atypical endometrial hyperplasia? Autophagy. 2011;7:74–82.
Giatromanolaki A, Koukourakis M, Koutsopoulos, et al. Autophagy and hypoxia in colonic adenomas related to aggressive features. Colorectal Dis. 2013;15:e223-30.
Liao W, Sun L, Wang C, Huang H, Liu J, Liao W, Shi M. LC3A-positive “stone-like” structures predict an adverse prognosis of gastric cancer. Anat Rec (Hoboken). 2014;297:653–62.
Xi SY, Lu JB, Chen JW, et al. The “stone-like” pattern of LC3A expression and its clinicopathologic significance in hepatocellular carcinoma. Biochem Biophys Res Commun. 2013;431:760–6.
Spowart JE, Townsend KN, Huwait H, et al. The autophagy protein LC3A correlates with hypoxia and is a prognostic marker of patient survival in clear cell ovarian cancer. J Pathol. 2012;228:437–47.
Sivridis E, Giatromanolaki A, Zois C, et al. The “stone-like” pattern of autophagy in human epithelial tumors and tumor-like lesions. An approach to the clinical outcome. Autophagy. 2010;6:122–5.
Feng Y, He D, Yao Z, Klionsky DJ. The machinery of macroautophagy. Cell Res. 2014;24:24–41.
Mizushima N. Autophagy: process and function. Genes Dev. 2007;21:2861–73.
Klionsky DJ, Baehrecke EH, Brumell JH, et al. A comprehensive glossary of autophagy-related molecules and processes (2nd ed.). Autophagy 2011;7:1273–94.
Musiwaro P, Smith M, Manifava M, et al. Characteristics and requirements of basal autophagy in HEK 293 cells. Autophagy. 2013;9:1407–17.
Li LT, Jiang G, Chen Q, et al. Ki67 is a promising molecular target in the diagnosis of cancer (review). Mol Med Rep. 2015;11:1566–72.
Joshi S, Schjølberg AR, Ekstrøm PO, et al. Tp53/p53 status in keratoacanthomas. J Cutan Pathol. 2016;43:571–8.
Watanabe IC, Magalhães RF, de Moraes AM, et al. Keratoacanthoma and keratoacanthoma-like squamous cell carcinoma: similar morphology but different pathogenesis. Medicine (Baltimore). 2015;94:e934.
Martinet W, Roth L, De Meyer GRY, Standard immunohistochemical assays to assess autophagy in mammalian tissue. Cells. 2017;6(3):17.
Brantsch KD, Meisner C, Schönfisch B, et al. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol. 2008;9:713–20.
Amorim E. Solitary fibrous tumor of the pleura: 3 case reports. Rev Assoc Med Bras. 2015;61:207–8.
Thway K, Ng W, Noujaim J, et al. The current status of solitary fibrous tumor: diagnostic features, variants, and genetics. Int J Surg Pathol. 2016;24:281–92.
Strickland KC, Nucci MR, Esselen KM, et al. Solitary fibrous tumor of the uterus presenting with lung metastases: a case report. Int J Gynecol Pathol. 2016;35:25–9.
Akahane K, Kato K, Ogiso S, Sakaguchi K, et al. Malignant granular cell tumor of the breast: case report and literature review. Breast Cancer. 2015;22:317–23.
Martignoni G, Pea M, Zampini C, et al. PEComas of the kidney and of the genitourinary tract. Semin Diagn Pathol. 2015;32:140–59.
Doyle LA, Hornick JL, Fletcher CD. PEComa of the gastrointestinal tract: clinicopathologic study of 35 cases with evaluation of prognostic parameters. Am J Surg Pathol. 2013;37:1769–82.
Do BA, Varshney R, Zawawi F, et al. Inflammatory myofibroblastic tumor of the larynx-a case report. J Voice. 2014;28:258–61.
Lai LM, McCarville MB, Kirby P, et al. Shedding light on inflammatory pseudotumor in children: spotlight on inflammatory myofibroblastic tumor. Pediatr Radiol. 2015;45:1738–52.
Strieth S, Hartschuh W, Pilz L, et al. Carcinoma-like vascular density in atypic keratoacanthoma suggests malignant progression. Br J Cancer. 2002;87:1301–7.
Chow TK, Chacko E, Cleary C, et al. Keratoacanthoma of the lower eyelid. Eye (Lond). 2005;19:689–90.
Clausen OP, Aass HC, Beigi M, et al. Are keratoacanthomas variants of squamous cell carcinomas? A comparison of chromosomal aberrations by comparative genomic hybridization. J Invest Dermatol. 2006;126:2308–15.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Sivridis, E., Koukourakis, I.M., Arelaki, S. et al. Patterns of LC3A Autophagy Protein Expression in Keratoacanthomas. Head and Neck Pathol 14, 150–155 (2020). https://doi.org/10.1007/s12105-019-01033-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12105-019-01033-1